Obesity and neuroinflammation: A pathway to cognitive impairment

Brain, Behavior, and Immunity

Volumn 42, Issue , 2014, Pages 10-21

  Miller, Alyson A ^a   Spencer, Sarah J ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Cognition; High fat diet; Hypothalamus; Inflammation; Obesity

Indexed keywords

CYTOKINE; FAT; FATTY ACID;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AMYLOID PLAQUE; APOPTOSIS; ARCUATE NUCLEUS; ARTICLE; ASTROCYTE; BODY MASS; BRAIN; BRAIN FUNCTION; BRAIN REGION; CALORIC RESTRICTION; CELL PROLIFERATION; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; FAT INTAKE; HUMAN; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; INFLAMMATION; LIPID DIET; MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; OVERNUTRITION; OXIDATIVE STRESS; PHYSICAL ACTIVITY; REWARD; RISK FACTOR; SATIETY; SYNAPSE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; COGNITION DISORDERS; COMPLICATION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; COGNITION; COGNITION DISORDERS; DIET, HIGH-FAT; HUMANS; HYPOTHALAMUS; INFLAMMATION; OBESITY;

EID: 84908651577     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.04.001     Document Type: Article

References (203)

1. Abiles V., Rodriguez-Ruiz S., Abiles J., Mellado C., Garcia A., Perez de la Cruz A., et al. Psychological characteristics of morbidly obese candidates for bariatric surgery. Obes. Surg. 2010, 20(2):161-167.
2. Alosco M.L., Galioto R., Spitznagel M.B., Strain G., Devlin M., Cohen R., et al. Cognitive function after bariatric surgery: evidence for improvement 3 years after surgery. Am. J. Surg. 2013.
3. Alosco M.L., Spitznagel M.B., Strain G., Devlin M., Cohen R., Paul R., et al. Improved memory function two years after bariatric surgery. Obesity (Silver Spring, Md) 2014, 22(1):32-38.
4. Alvarez J.A., Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychol. Rev. 2006, 16(1):17-42.
5. Amieva H., Jacqmin-Gadda H., Orgogozo J.M., Le Carret N., Helmer C., Letenneur L., et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 2005, 128(Pt 5):1093-1101.
6. Anstey K.J., Cherbuin N., Budge M., Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes. Rev. 2011, 12(5):e426-e437.
7. Balakrishnan K., Verdile G., Mehta P.D., Beilby J., Nolan D., Galvao D.A., et al. Plasma Abeta42 correlates positively with increased body fat in healthy individuals. J. Alzheimers Dis. 2005, 8(3):269-282.
8. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discovery 2004, 3(3):205-214.
9. Barrientos R.M., Frank M.G., Crysdale N.Y., Chapman T.R., Ahrendsen J.T., Day H.E., et al. Little exercise, big effects: reversing aging and infection-induced memory deficits, and underlying processes. J. Neurosci. 2011, 31(32):11578-11586.
10. Beydoun M.A., Beydoun H.A., Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes. Rev. 2008, 9(3):204-218.
11. Bilbo S.D., Tsang V. Enduring consequences of maternal obesity for brain inflammation and behavior of offspring. FASEB J. 2010, 24(6):2104-2115.
12. Biro F.M., Wien M. Childhood obesity and adult morbidities. Am. J. Clin. Nutr. 2010, 91(5):1499S-1505S.
13. Blatteis C.M. The onset of fever: new insights into its mechanism. Prog. Brain Res. 2007, 162:3-14.
14. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 1995, 202(1-2):17-20.
15. Borges B.C., Rorato R., Avraham Y., da Silva L.E., Castro M., Vorobiav L., et al. Leptin resistance and desensitization of hypophagia during prolonged inflammatory challenge. Am. J. Physiol. Endocrinol. Metab. 2011, 300(5):E858-E869.
16. Bouchard J., Truong J., Bouchard K., Dunkelberger D., Desrayaud S., Moussaoui S., et al. Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease. J. Neurosci. 2012, 32(50):18259-18268.
17. Braun T.P., Zhu X., Szumowski M., Scott G.D., Grossberg A.J., Levasseur P.R., et al. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J. Exp. Med. 2011, 208(12):2449-2463.
18. Brooks S.J., Benedict C., Burgos J., Kempton M.J., Kullberg J., Nordenskjold R., et al. Late-life obesity is associated with smaller global and regional gray matter volumes: a voxel-based morphometric study. Int. J. Obes. 2013, 37(2):230-236.
19. Bruehl H., Wolf O.T., Sweat V., Tirsi A., Richardson S., Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 2009, 1280:186-194.
20. Cai D., Liu T. Inflammatory cause of metabolic syndrome via brain stress and NF-kappaB. Aging 2012, 4(2):98-115.
21. Cai Z., Yan Y., Wang Y. Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder. Clin. Interv. Aging 2013, 8:1089-1095.
22. Cakir I., Cyr N.E., Perello M., Litvinov B.P., Romero A., Stuart R.C., et al. Obesity induces hypothalamic endoplasmic reticulum stress and impairs proopiomelanocortin (POMC) post-translational processing. J. Biol. Chem. 2013, 288(24):17675-17688.
23. Castro G., C.Areias M.F., Weissmann L., Quaresma P.G., Katashima C.K., Saad M.J., et al. Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats. FEBS Open Bio 2013, 3:443-449.
24. Cattin L., Bordin P., Fonda M., Adamo C., Barbone F., Bovenzi M., et al. Factors associated with cognitive impairment among older Italian inpatients. Gruppo Italiano di Farmacovigilanza nell'Anziano (G.I.F.A.). J. Am. Geriatr. Soc. 1997, 45(11):1324-1330.
25. Cazettes F., Cohen J.I., Yau P.L., Talbot H., Convit A. Obesity-mediated inflammation may damage the brain circuit that regulates food intake. Brain Res. 2011, 1373:101-109.
26. Chen Y.C., Chen T.F., Yip P.K., Hu C.Y., Chu Y.M., Chen J.H. Body mass index (BMI) at an early age and the risk of dementia. Arch. Gerontol. Geriatr. 2010, 50(Suppl. 1):S48-S52.
27. Clark R.A., Valente A.J. Nuclear factor kappa B activation by NADPH oxidases. Mech. Ageing Dev. 2004, 125(10-11):799-810.
28. Cournot M., Marquie J.C., Ansiau D., Martinaud C., Fonds H., Ferrieres J., et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 2006, 67(7):1208-1214.
29. Cserjesi R., Molnar D., Luminet O., Lenard L. Is there any relationship between obesity and mental flexibility in children?. Appetite 2007, 49(3):675-678.
30. Cullinan S.B., Diehl J.A. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int. J. Biochem. Cell Biol. 2006, 38(3):317-332.
31. Dahl A.K., Lopponen M., Isoaho R., Berg S., Kivela S.L. Overweight and obesity in old age are not associated with greater dementia risk. J. Am. Geriatr. Soc. 2008, 56(12):2261-2266.
32. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L., Boschero A.C., et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146(10):4192-4199.
33. Debette S., Seshadri S., Beiser A., Au R., Himali J.J., Palumbo C., et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011, 77(5):461-468.
34. Doyle A.C., le Grange D., Goldschmidt A., Wilfley D.E. Psychosocial and physical impairment in overweight adolescents at high risk for eating disorders. Obesity (Silver Spring, Md) 2007, 15(1):145-154.
35. Egeland J., Lund A., Landro N.I., Rund B.R., Sundet K., Asbjornsen A., et al. Cortisol level predicts executive and memory function in depression, symptom level predicts psychomotor speed. Acta Psychiatr. Scand. 2005, 112(6):434-441.
36. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Nat. Acad. Sci. USA 2003, 100(23):13632-13637.
37. Elias M.F., Beiser A., Wolf P.A., Au R., White R.F., D'Agostino R.B. The preclinical phase of alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch. Neurol. 2000, 57(6):808-813.
38. Elias M.F., Elias P.K., Sullivan L.M., Wolf P.A., D'Agostino R.B. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int. J. Obes. Relat. Metab. Disord. 2003, 27(2):260-268.
39. Elias M.F., Elias P.K., Sullivan L.M., Wolf P.A., D'Agostino R.B. Obesity, diabetes and cognitive deficit: the Framingham Heart Study. Neurobiol. Aging 2005, 26(Suppl. 1):11-16.
40. Enzinger C., Fazekas F., Matthews P.M., Ropele S., Schmidt H., Smith S., et al. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 2005, 64(10):1704-1711.
41. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. J. Leukoc. Biol. 2010, 87(6):989-999.
42. Erta M., Quintana A., Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int. J. Biol. Sci. 2012, 8(9):1254-1266.
43. Fitzpatrick A.L., Kuller L.H., Lopez O.L., Diehr P., O'Meara E.S., Longstreth W.T., et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch. Neurol. 2009, 66(3):336-342.
44. Fonseca A.C., Ferreiro E., Oliveira C.R., Cardoso S.M., Pereira C.F. Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells. Biochim. Biophys. Acta 2013, 1832(12):2191-2203.
45. Fotuhi M., Do D., Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat. Rev. Neurol. 2012, 8(4):189-202.
46. Freeman L.R., Zhang L., Nair A., Dasuri K., Francis J., Fernandez-Kim S.O., et al. Obesity increases cerebrocortical reactive oxygen species and impairs brain function. Free Radical Biol. Med. 2013, 56:226-233.
47. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 2006, 393(Pt 1):7-20.
48. Gazdzinski S., Kornak J., Weiner M.W., Meyerhoff D.J. Body mass index and magnetic resonance markers of brain integrity in adults. Ann. Neurol. 2008, 63(5):652-657.
49. Gazdzinski S., Millin R., Kaiser L.G., Durazzo T.C., Mueller S.G., Weiner M.W., et al. BMI and neuronal integrity in healthy, cognitively normal elderly: a proton magnetic resonance spectroscopy study. Obesity 2010, 18(4):743-748.
50. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., et al. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Nat. Acad. Sci. USA 1989, 86(19):7606-7610.
51. Gorelick P.B. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann. N. Y. Acad. Sci. 2010, 1207:155-162.
52. Gorelick P.B., Scuteri A., Black S.E., Decarli C., Greenberg S.M., Iadecola C., et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011, 42(9):2672-2713.
53. Gorospe E.C., Dave J.K. The risk of dementia with increased body mass index. Age Ageing 2007, 36(1):23-29.
54. Grayson B.E., Fitzgerald M.F., Hakala-Finch A.P., Ferris V.M., Begg D.P., Tong J., et al. Improvements in hippocampal-dependent memory and microglial infiltration with calorie restriction and gastric bypass surgery, but not with vertical sleeve gastrectomy. Int. J. Obes. (Lond.) 2014, 38(3):349-356.
55. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29:415-445.
56. Griffin E.W., Skelly D.T., Murray C.L., Cunningham C. Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction. J. Neurosci. 2013, 33(38):15248-15258.
57. Gunstad J., Paul R.H., Cohen R.A., Tate D.F., Spitznagel M.B., Gordon E. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr. Psychiatry 2007, 48(1):57-61.
58. Gunstad J., Spitznagel M.B., Paul R.H., Cohen R.A., Kohn M., Luyster F.S., et al. Body mass index and neuropsychological function in healthy children and adolescents. Appetite 2008, 50(2-3):246-251.
59. Gunstad J., Lhotsky A., Wendell C.R., Ferrucci L., Zonderman A.B. Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging. Neuroepidemiology 2010, 34(4):222-229.
60. Gustafson D. Adiposity indices and dementia. Lancet Neurol. 2006, 5(8):713-720.
61. Gustafson D., Rothenberg E., Blennow K., Steen B., Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch. Intern. Med. 2003, 163(13):1524-1528.
62. Gustafson D., Lissner L., Bengtsson C., Bjorkelund C., Skoog I. A 24-year follow-up of body mass index and cerebral atrophy. Neurology 2004, 63(10):1876-1881.
63. Gustafson D.R., Backman K., Waern M., Ostling S., Guo X., Zandi P., et al. Adiposity indicators and dementia over 32years in Sweden. Neurology 2009, 73(19):1559-1566.
64. Gustafson D.R., Backman K., Joas E., Waern M., Ostling S., Guo X., et al. 37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden. J. Alzheimers Dis. 2012, 28(1):163-171.
65. Hall J.R., Wiechmann A.R., Johnson L.A., Edwards M., Barber R.C., Winter A.S., et al. Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease. J. Alzheimers Dis. 2013, 35(2):363-371.
66. Haslam D.W., James W.P. Obesity. Lancet 2005, 366(9492):1197-1209.
67. Hillman J.B., Dorn L.D., Loucks T.L., Berga S.L. Obesity and the hypothalamic-pituitary-adrenal axis in adolescent girls. Metab., Clin. Exp. 2012, 61(3):341-348.
68. Hirabara S.M., Gorjao R., Vinolo M.A., Rodrigues A.C., Nachbar R.T., Curi R. Molecular targets related to inflammation and insulin resistance and potential interventions. J Biomed Biotechnol. 2012, 2012:379024.
69. Holcke M., Marcus C., Gillberg C., Fernell E. Paediatric obesity: a neurodevelopmental perspective. Acta Paediatr. 2008, 97(6):819-821.
70. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140(6):900-917.
71. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259(5091):87-91.
72. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95(5):2409-2415.
73. Howard J.K., Flier J.S. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol. Metab. 2006, 17(9):365-371.
74. Jack C.R., Shiung M.M., Weigand S.D., O'Brien P.C., Gunter J.L., Boeve B.F., et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005, 65(8):1227-1231.
75. Jagust W., Harvey D., Mungas D., Haan M. Central obesity and the aging brain. Arch. Neurol. 2005, 62(10):1545-1548.
76. Jeon B.T., Jeong E.A., Shin H.J., Lee Y., Lee D.H., Kim H.J., et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012, 61(6):1444-1454.
77. Johnson J.D., O'Connor K.A., Deak T., Stark M., Watkins L.R., Maier S.F. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav. Immun. 2002, 16(4):461-476.
78. Julien C., Tremblay C., Phivilay A., Berthiaume L., Emond V., Julien P., et al. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol. Aging 2010, 31(9):1516-1531.
79. Jurdak N., Lichtenstein A.H., Kanarek R.B. Diet-induced obesity and spatial cognition in young male rats. Nutr. Neurosci. 2008, 11(2):48-54.
80. Kanaya A.M., Lindquist K., Harris T.B., Launer L., Rosano C., Satterfield S., et al. Total and regional adiposity and cognitive change in older adults: the Health, Aging and Body Composition (ABC) study. Arch. Neurol. 2009, 66(3):329-335.
81. Kawai T., Akira S. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 2005, 17(4):338-344.
82. Kerr D.S., Campbell L.W., Applegate M.D., Brodish A., Landfield P.W. Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging. J. Neurosci. 1991, 11(5):1316-1324.
83. Kivipelto M., Ngandu T., Fratiglioni L., Viitanen M., Kareholt I., Winblad B., et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 2005, 62(10):1556-1560.
84. Kleinridders A., Schenten D., Konner A.C., Belgardt B.F., Mauer J., Okamura T., et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 2009, 10(4):249-259.
85. Koessler S., Engler H., Riether C., Kissler J. No retrieval-induced forgetting under stress. Psychol. Sci. 2009, 20(11):1356-1363.
86. Kuo H.K., Jones R.N., Milberg W.P., Tennstedt S., Talbot L., Morris J.N., et al. Cognitive function in normal-weight, overweight, and obese older adults: an analysis of the Advanced Cognitive Training for Independent and Vital Elderly cohort. J. Am. Geriatr. Soc. 2006, 54(1):97-103.
87. Leboucher A., Laurent C., Fernandez-Gomez F.J., Burnouf S., Troquier L., Eddarkaoui S., et al. Detrimental effects of diet-induced obesity on tau pathology are independent of insulin resistance in tau transgenic mice. Diabetes 2013, 62(5):1681-1688.
88. Lee J.W., Lee Y.K., Yuk D.Y., Choi D.Y., Ban S.B., Oh K.W., et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflamm. 2008, 5:37.
89. Lee Y.H., Martin J.M., Maple R.L., Tharp W.G., Pratley R.E. Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals. Neuroendocrinology 2009, 90(4):383-390.
90. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Nat. Acad. Sci. USA 2003, 100(14):8514-8519.
91. Levin-Allerhand J.A., Lominska C.E., Smith J.D. Increased amyloid-levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J. Nutr. Health Aging 2002, 6(5):315-319.
92. Li Y., Dai Q., Jackson J.C., Zhang J. Overweight is associated with decreased cognitive functioning among school-age children and adolescents. Obesity 2008, 16(8):1809-1815.
93. Li W., Prakash R., Chawla D., Du W., Didion S.P., Filosa J.A., et al. Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304(11):R1001-R1008.
94. Liang J., Matheson B.E., Kaye W.H., Boutelle K.N. Neurocognitive correlates of obesity and obesity-related behaviors in children and adolescents. Int. J. Obes. 2014, 38(4):494-506.
95. Loane D.J., Byrnes K.R. Role of microglia in neurotrauma. Neurotherapeutics 2010, 7(4):366-377.
96. Loos R.J. Recent progress in the genetics of common obesity. Br. J. Clin. Pharmacol. 2009, 68(6):811-829.
97. Lu P., Gonzales C., Chen Y., Adedoyin A., Hummel M., Kennedy J.D., et al. CNS penetration of small molecules following local inflammation, widespread systemic inflammation or direct injury to the nervous system. Life Sci. 2009, 85(11-12):450-456.
98. Lu J., Wu D.M., Zheng Y.L., Hu B., Cheng W., Zhang Z.F., et al. Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and IkappaB kinase beta/nuclear factor-kappaB-mediated inflammatory pathways in mice. Brain Behav. Immun. 2011, 25(8):1658-1667.
99. Lynch C.M., Kinzenbaw D.A., Chen X., Zhan S., Mezzetti E., Filosa J., et al. Nox2-derived superoxide contributes to cerebral vascular dysfunction in diet-induced obesity. Stroke 2013, 44(11):3195-3201.
100. Maayan L., Hoogendoorn C., Sweat V., Convit A. Disinhibited eating in obese adolescents is associated with orbitofrontal volume reductions and executive dysfunction. Obesity 2011, 19(7):1382-1387.
101. MacQueen G., Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?. Mol. Psychiatry 2011, 16(3):252-264.
102. Maesako M., Uemura K., Kubota M., Kuzuya A., Sasaki K., Asada M., et al. Environmental enrichment ameliorated high-fat diet-induced Abeta deposition and memory deficit in APP transgenic mice. Neurobiol. Aging 2012, 33(5). 1011 e1011-1023.
103. Maesako M., Uemura K., Kubota M., Kuzuya A., Sasaki K., Hayashida N., et al. Exercise is more effective than diet control in preventing high fat diet-induced beta-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J. Biol. Chem. 2012, 287(27):23024-23033.
104. Magarinos A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 1995, 69(1):89-98.
105. Maric T., Woodside B., Luheshi G.N. The effects of dietary saturated fat on basal hypothalamic neuroinflammation in rats. Brain Behav. Immun. 2014, 36:35-45.
106. Marioni R.E., Strachan M.W., Reynolds R.M., Lowe G.D., Mitchell R.J., Fowkes F.G., et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010, 59(3):710-713.
107. McEwen B.S., Weiss J.M., Schwartz L.S. Selective retention of corticosterone by limbic structures in rat brain. Nature 1968, 220(5170):911-912.
108. McNay D.E., Briancon N., Kokoeva M.V., Maratos-Flier E., Flier J.S. Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J. Clin. Invest. 2012, 122(1):142-152.
109. Milanski M., Degasperi G., Coope A., Morari J., Denis R., Cintra D.E., et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci. 2009, 29(2):359-370.
110. Miller L.A., Crosby R.D., Galioto R., Strain G., Devlin M.J., Wing R., et al. Bariatric surgery patients exhibit improved memory function 12 months postoperatively. Obes. Surg. 2013, 23(10):1527-1535.
111. Miyamoto A., Wake H., Moorhouse A.J., Nabekura J. Microglia and synapse interactions: fine tuning neural circuits and candidate molecules. Front. Cell. Neurosci. 2013, 7:70.
112. Molteni R., Barnard R.J., Ying Z., Roberts C.K., Gomez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 2002, 112(4):803-814.
113. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302(5651):1760-1765.
114. Moraes J.C., Coope A., Morari J., Cintra D.E., Roman E.A., Pauli J.R., et al. High-fat diet induces apoptosis of hypothalamic neurons. PLoS One 2009, 4(4):e5045.
115. Moroz N., Tong M., Longato L., Xu H., de la Monte S.M. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J. Alzheimers Dis. 2008, 15(1):29-44.
116. Morrison C.D., Pistell P.J., Ingram D.K., Johnson W.D., Liu Y., Fernandez-Kim S.O., et al. High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice. implications for decreased Nrf2 signaling. J. Neurochem. 2010, 114(6):1581-1589.
117. Mrak R.E. Alzheimer-type neuropathological changes in morbidly obese elderly individuals. Clin. Neuropathol. 2009, 28(1):40-45.
118. Mrak R.E., Griffin W.S. Potential inflammatory biomarkers in Alzheimer's disease. J. Alzheimers Dis. 2005, 8(4):369-375.
119. Mueller K., Anwander A., Moller H.E., Horstmann A., Lepsien J., Busse F., et al. Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging. PLoS One 2011, 6(4):e18544.
120. Nadanaka S., Okada T., Yoshida H., Mori K. Role of disulfide bridges formed in the luminal domain of ATF6 in sensing endoplasmic reticulum stress. Mol. Cell. Biol. 2007, 27(3):1027-1043.
121. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012, 307(5):483-490.
122. Orsucci D., Mancuso M., Filosto M., Siciliano G. Tetracyclines and neuromuscular disorders. Curr. Neuropharmacol. 2012, 10(2):134-138.
123. Pannacciulli N., Del Parigi A., Chen K., Le D.S., Reiman E.M., Tataranni P.A. Brain abnormalities in human obesity: a voxel-based morphometric study. NeuroImage 2006, 31(4):1419-1425.
124. Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333(6048):1456-1458.
125. Patki G., Solanki N., Atrooz F., Allam F., Salim S. Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain Res. 2013, 1539:73-86.
126. Pedersen M., Pedersen K.K., Bruunsgaard H., Krabbe K.S., Thomsen C., Faerch K., et al. Cognitive functions in middle aged individuals are related to metabolic disturbances and aerobic capacity: a cross-sectional study. PLoS One 2012, 7(12):e51132.
127. Pepping J.K., Freeman L.R., Gupta S., Keller J.N., Bruce-Keller A.J. NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2013, 304(4):E392-E404.
128. Pickup J.C., Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998, 41(10):1241-1248.
129. Pistell P.J., Morrison C.D., Gupta S., Knight A.G., Keller J.N., Ingram D.K., et al. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J. Neuroimmunol. 2010, 219(1-2):25-32.
130. Posey K.A., Clegg D.J., Printz R.L., Byun J., Morton G.J., Vivekanandan-Giri A., et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2009, 296(5):E1003-E1012.
131. Puig K.L., Floden A.M., Adhikari R., Golovko M.Y., Combs C.K. Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity. PLoS One 2012, 7(1):e30378.
132. Purkayastha S., Cai D. Disruption of neurogenesis by hypothalamic inflammation in obesity or aging. Rev. Endocr. Metab. Disord. 2013, 14(4):351-356.
133. Qin H., Roberts K.L., Niyongere S.A., Cong Y., Elson C.O., Benveniste E.N. Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. J. Immunol. 2007, 179(9):5966-5976.
134. Raber J. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits. Mol. Neurobiol. 1998, 18(1):1-22.
135. Raji C.A., Ho A.J., Parikshak N.N., Becker J.T., Lopez O.L., Kuller L.H., et al. Brain structure and obesity. Hum. Brain Mapp. 2010, 31(3):353-364.
136. Rao R.V., Ellerby H.M., Bredesen D.E. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 2004, 11(4):372-380.
137. Raz N., Lindenberger U., Rodrigue K.M., Kennedy K.M., Head D., Williamson A., et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb. Cortex 2005, 15(11):1676-1689.
138. Reinert K.R., Po'e E.K., Barkin S.L. The relationship between executive function and obesity in children and adolescents: a systematic literature review. J. Obes. 2013, 2013:820956.
139. Ringheim G.E., Szczepanik A.M., Petko W., Burgher K.L., Zhu S.Z., Chao C.C. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. Brain Res. Mol. Brain Res. 1998, 55(1):35-44.
140. Rivera P., Perez-Martin M., Pavon F.J., Serrano A., Crespillo A., Cifuentes M., et al. Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampus. PLoS One 2013, 8(5):e64750.
141. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 2007, 8(7):519-529.
142. Sabia S., Kivimaki M., Shipley M.J., Marmot M.G., Singh-Manoux A. Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study. Am. J. Clin. Nutr. 2009, 89(2):601-607.
143. Sapolsky R.M. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J. Neurosci. 1985, 5(5):1228-1232.
144. Sapolsky R.M. Why stress is bad for your brain. Science 1996, 273(5276):749-750.
145. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 2000, 57(10):925-935.
146. Sapolsky R.M., McEwen B.S., Rainbow T.C. Quantitative autoradiography of [3H]corticosterone receptors in rat brain. Brain Res. 1983, 271(2):331-334.
147. Sasaki A., de Vega W.C., St-Cyr S., Pan P., McGowan P.O. Perinatal high fat diet alters glucocorticoid signaling and anxiety behavior in adulthood. Neuroscience 2013, 240:1-12.
148. Schram M.T., Euser S.M., de Craen A.J., Witteman J.C., Frolich M., Hofman A., et al. Systemic markers of inflammation and cognitive decline in old age. J. Am. Geriatr. Soc. 2007, 55(5):708-716.
149. Scott K.M., McGee M.A., Wells J.E., Oakley Browne M.A. Obesity and mental disorders in the adult general population. J. Psychosom. Res. 2008, 64(1):97-105.
150. Shin A.C., Zheng H., Berthoud H.R. An expanded view of energy homeostasis: neural integration of metabolic, cognitive, and emotional drives to eat. Physiol. Behav. 2009, 97(5):572-580.
151. Shu C.J., Benoist C., Mathis D. The immune system's involvement in obesity-driven type 2 diabetes. Semin. Immunol. 2012, 24(6):436-442.
152. Sokka A.L., Putkonen N., Mudo G., Pryazhnikov E., Reijonen S., Khiroug L., et al. Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain. J. Neurosci. 2007, 27(4):901-908.
153. Spencer S.J. Perinatal nutrition programs neuroimmune function long-term: mechanisms and implications. Front. Neurosci. 2013, 7:144.
154. Spencer S.J., Tilbrook A. The glucocorticoid contribution to obesity. Stress (Amsterdam, Netherlands) 2011, 14(3):233-246.
155. Spencer S.J., Galic M.A., Pittman Q.J. Neonatal programming of innate immune function. Am. J. Physiol. Endocrinol. Metab. 2011, 300(1):E11-E18.
156. Starkman M.N., Gebarski S.S., Berent S., Schteingart D.E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol. Psychiatry 1992, 32(9):756-765.
157. Stewart R., Masaki K., Xue Q.L., Peila R., Petrovitch H., White L.R., et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch. Neurol. 2005, 62(1):55-60.
158. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 2008, 11(3):309-317.
159. Stranahan A.M., Norman E.D., Lee K., Cutler R.G., Telljohann R.S., Egan J.M., et al. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 2008, 18(11):1085-1088.
160. Stranahan A.M., Cutler R.G., Button C., Telljohann R., Mattson M.P. Diet-induced elevations in serum cholesterol are associated with alterations in hippocampal lipid metabolism and increased oxidative stress. J. Neurochem. 2011, 118(4):611-615.
161. Stranahan A.M., Martin B., Maudsley S. Anti-inflammatory effects of physical activity in relationship to improved cognitive status in humans and mouse models of Alzheimer's disease. Curr. Alzheimer Res. 2012, 9(1):86-92.
162. Studzinski C.M., Li F., Bruce-Keller A.J., Fernandez-Kim S.O., Zhang L., Weidner A.M., et al. Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP×PS1 knock-in mice. J. Neurochem. 2009, 108(4):860-866.
163. Tabas I., Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 2011, 13(3):184-190.
164. Taki Y., Kinomura S., Sato K., Inoue K., Goto R., Okada K., et al. Relationship between body mass index and gray matter volume in 1428 healthy individuals. Obesity 2008, 16(1):119-124.
165. Tarkowski E., Issa R., Sjogren M., Wallin A., Blennow K., Tarkowski A., et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol. Aging 2002, 23(2):237-243.
166. Thaler J.P., Schwartz M.W. Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 2010, 151(9):4109-4115.
167. Thaler J.P., Yi C.X., Schur E.A., Guyenet S.J., Hwang B.H., Dietrich M.O., et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 2012, 122(1):153-162.
168. Thirumangalakudi L., Prakasam A., Zhang R., Bimonte-Nelson H., Sambamurti K., Kindy M.S., et al. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J. Neurochem. 2008, 106(1):475-485.
169. Tikka T.M., Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 2001, 166(12):7527-7533.
170. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 2001, 21(8):2580-2588.
171. Tremblay M.E., Lowery R.L., Majewska A.K. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010, 8(11):e1000527.
172. Trollor J.N., Smith E., Agars E., Kuan S.A., Baune B.T., Campbell L., et al. The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) 2012, 34(5):1295-1308.
173. Tucsek Z., Toth P., Sosnowska D., Gautam T., Mitschelen M., Koller A., et al. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse Hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease. J. Gerontol. 2013, [Epub ahead of print].
174. Turchan-Cholewo J., Dimayuga V.M., Gupta S., Gorospe R.M., Keller J.N., Bruce-Keller A.J. NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat. Antioxid. Redox Signal. 2009, 11(2):193-204.
175. Uehara T., Nakamura T., Yao D., Shi Z.Q., Gu Z., Ma Y., et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006, 441(7092):513-517.
176. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389(6651):610-614.
177. van Dijk E.J., Prins N.D., Vermeer S.E., Vrooman H.A., Hofman A., Koudstaal P.J., et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005, 112(6):900-905.
178. Veena S.R., Hegde B.G., Ramachandraiah S., Krishnaveni G.V., Fall C.H., Srinivasan K. Relationship between adiposity and cognitive performance in 9-10-year-old children in South India. Arch. Dis. Child. 2014, 99(2):126-134.
179. Verdejo-Garcia A., Perez-Exposito M., Schmidt-Rio-Valle J., Fernandez-Serrano M.J., Cruz F., Perez-Garcia M., et al. Selective alterations within executive functions in adolescents with excess weight. Obesity 2010, 18(8):1572-1578.
180. Viscogliosi G., Andreozzi P., Chiriac I.M., Cipriani E., Servello A., Marigliano B., et al. Depressive symptoms in older people with metabolic syndrome: is there a relationship with inflammation?. Int. J. Geriatr. Psychiatry 2013, 28(3):242-247.
181. Wake H., Moorhouse A.J., Jinno S., Kohsaka S., Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009, 29(13):3974-3980.
182. Ward M.A., Carlsson C.M., Trivedi M.A., Sager M.A., Johnson S.C. The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol. 2005, 5:23.
183. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112(12):1796-1808.
184. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 112(12):1785-1788.
185. West N.A., Haan M.N. Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64(1):103-109.
186. White C.L., Pistell P.J., Purpera M.N., Gupta S., Fernandez-Kim S.O., Hise T.L., et al. Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet. Neurobiol. Dis. 2009, 35(1):3-13.
187. Whitmer R.A., Gunderson E.P., Quesenberry C.P., Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr. Alzheimer Res. 2007, 4(2):103-109.
188. Whitmer R.A., Gustafson D.R., Barrett-Connor E., Haan M.N., Gunderson E.P., Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008, 71(14):1057-1064.
189. WHO (2013). Obesity and overweight. http://www.who.int/.
190. Williams L.M. Hypothalamic dysfunction in obesity. Proc. Nutr. Soc. 2012, 71(4):521-533.
191. Winocur G., Greenwood C.E. Studies of the effects of high fat diets on cognitive function in a rat model. Neurobiol. Aging 2005, 26(Suppl. 1):46-49.
192. Wohleb E.S., McKim D.B., Shea D.T., Powell N.D., Tarr A.J., Sheridan J.F., et al. Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol. Psychiatry 2013, [Epub ahead of print]. 10.1016/j.biopsych.2013.11.029.
193. Wohleb E.S., Powell N.D., Godbout J.P., Sheridan J.F. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. Neurosci. 2013, 33(34):13820-13833.
194. Woolley C.S., Gould E., McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 1990, 531(1-2):225-231.
195. Wu A., Molteni R., Ying Z., Gomez-Pinilla F. A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neuroscience 2003, 119(2):365-375.
196. Xia Y., Krukoff T.L. Differential neuronal activation in the hypothalamic paraventricular nucleus and autonomic/neuroendocrine responses to I.C.V. endotoxin. Neuroscience 2003, 121(1):219-231.
197. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112(12):1821-1830.
198. Yau P.L., Castro M.G., Tagani A., Tsui W.H., Convit A. Obesity and metabolic syndrome and functional and structural brain impairments in adolescence. Pediatrics 2012, 130(4):e856-e864.
199. Ye L., Huang Y., Zhao L., Li Y., Sun L., Zhou Y., et al. IL-1beta and TNF-alpha induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J. Neurochem. 2013, 125(6):897-908.
200. Yokum S., Ng J., Stice E. Relation of regional gray and white matter volumes to current BMI and future increases in BMI: a prospective MRI study. Int. J. Obes. 2012, 36(5):656-664.
201. Zhang X., Dong F., Ren J., Driscoll M.J., Culver B. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp. Neurol. 2005, 191(2):318-325.
202. Zhang X., Zhang G., Zhang H., Karin M., Bai H., Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008, 135(1):61-73.
203. Zhang L., Dasuri K., Fernandez-Kim S.O., Bruce-Keller A.J., Freeman L.R., Pepping J.K., et al. Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: implications for studying obesity-brain interactions in mice. Biochim. Biophys. Acta 2013, 1832(9):1456-1462.